-+ 0.00%
-+ 0.00%
-+ 0.00%

Poxel names Laure-Hélène Mercier board chair, replacing Sophie Jacq Lapointe

PUBT·09/03/2026 17:15:25
Listen to the news
Poxel names Laure-Hélène Mercier board chair, replacing Sophie Jacq Lapointe
  • Poxel appointed Laure-Hélène Mercier as chair of the board, effective Sept. 3, 2026, replacing Sophie Jacq Lapointe.
  • Mercier has more than 20 years’ experience spanning biotech and financial markets.
  • She joined Innate Pharma in 2007, holding investor relations, finance, strategy roles, including CFO and executive board member.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Poxel SA published the original content used to generate this news brief via Business Wire (Ref. ID: 20260903052809) on September 03, 2026, and is solely responsible for the information contained therein.